Your browser doesn't support javascript.
loading
MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission.
He, Enqi; Lozano, Miguel A Gonzalez; Stringer, Sven; Watanabe, Kyoko; Sakamoto, Kensuke; den Oudsten, Frank; Koopmans, Frank; Giamberardino, Stephanie N; Hammerschlag, Anke; Cornelisse, L Niels; Li, Ka Wan; van Weering, Jan; Posthuma, Danielle; Smit, August B; Sullivan, Patrick F; Verhage, Matthijs.
Affiliation
  • He E; Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Lozano MAG; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Stringer S; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Watanabe K; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Sakamoto K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, 171 77 Stockholm, Sweden.
  • den Oudsten F; Department of Genetics, Center for Psychiatric Genomics, University of North Carolina at Chapel Hill, NC, USA.
  • Koopmans F; Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Giamberardino SN; Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Hammerschlag A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, 171 77 Stockholm, Sweden.
  • Cornelisse LN; Department of Genetics, Center for Psychiatric Genomics, University of North Carolina at Chapel Hill, NC, USA.
  • Li KW; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • van Weering J; Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Posthuma D; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Smit AB; Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Sullivan PF; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Verhage M; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
Hum Mol Genet ; 27(11): 1879-1891, 2018 06 01.
Article in En | MEDLINE | ID: mdl-29635364
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / MicroRNAs / Proteomics Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / MicroRNAs / Proteomics Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2018 Type: Article